Bluejay Diagnostics Implements 1-for-50 Reverse Stock SplitBluejay Diagnostics, Inc. (NASDAQ: BJDX) recently announced a significant development in its corporate structure with the completion of a reverse stock split. The decision for the reverse sto

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Bluejay Diagnostics’s 8K filing here.

Bluejay Diagnostics Company Profile

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.